Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations

J Thorac Oncol. 2012 May;7(5):775-6. doi: 10.1097/JTO.0b013e318251980b.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • ErbB Receptors / genetics*
  • Female
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Mutation, Missense / genetics*
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Quinazolines
  • EGFR protein, human
  • ErbB Receptors
  • Gefitinib